Carl Zeiss Meditec AG

AFXA

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,798

Stocks News & Analysis

stocks

OpenAI is going public as the worst value among its peers

Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks

Wide moat healthcare leader remains undervalued

ASX healthcare giant expected to see uptick in demand from emerging markets.
stocks

This US AI winner has been unstoppable. Is it time to sell?

Astonishing results have driven this AI stock into significantly overvalued territory.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,858.8076.70-0.86%
CAC 408,244.290.000.00%
DAX 4024,944.95149.010.60%
Dow JONES (US)51,561.93874.861.73%
FTSE 10010,360.3228.020.27%
HKSE25,014.66238.74-0.95%
NASDAQ26,830.9623.02-0.09%
Nikkei 22566,791.52679.16-1.01%
NZX 50 Index13,161.9760.360.46%
S&P 5007,584.3130.630.41%
S&P/ASX 2008,629.6075.50-0.87%
SSE Composite Index4,059.001.220.03%

Market Movers